Trident Lifeline Limited
Nav Capital sold 75,000 shares of Trident Lifeline Limited for ₹2.10 Cr at ₹280.51 apiece in a bulk deal.
A pharmaceutical manufacturer incorporated in 2014, Trident Lifeline produces and distributes a comprehensive range of pharmaceutical products across India's healthcare sector. The company operates in the generics segment, focusing on formulations for various therapeutic areas and medical conditions. Its operations span manufacturing facilities, quality control protocols, and distribution networks designed to serve healthcare providers, hospitals, and patients nationwide through established channels.
Nav Capital is an India-focused investment platform whose Nav Capital VCC Emerging Star Fund is among the most active foreign portfolio investors anchoring Indian SME IPOs. It pursues high-conviction investing across private and public markets.